Arcutis Biotherapeutics Inc (ARQT) is near the top in its industry group according to InvestorsObserver. ARQT gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Arcutis Biotherapeutics Inc gets a 76 rank in the Biotechnology industry. Biotechnology is number 24 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Arcutis Biotherapeutics Inc Stock Today?
Arcutis Biotherapeutics Inc (ARQT) stock is lower by -3.74% while the S&P 500 is up 0.18% as of 11:53 AM on Wednesday, Feb 3. ARQT is down -$1.35 from the previous closing price of $36.10 on volume of 940,229 shares. Over the past year the S&P 500 has risen 16.24% while ARQT is up 35.53%. ARQT lost -$3.45 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Arcutis Biotherapeutics Inc (ARQT) Stock.
